E. Bajwa

发表

Augmenting communication and decision making in the intensive care unit with a cardiopulmonary resuscitation video decision support tool: a temporal intervention study.

J. Temel, R. Wiener, B. Thompson, 2012, Journal of palliative medicine.

Interferon-γ1b Therapy in Idiopathic Pulmonary Fibrosis: A Metaanalysis

A. Malhotra, N. Ayas, J. Ryu, 2005 .

Critical care 2 High-fl ow oxygen therapy and other inhaled therapies in intensive care units

D. Hess, K. Hibbert, E. Bajwa, 2016 .

High-flow oxygen therapy and other inhaled therapies in intensive care units

D. Hess, K. Hibbert, E. Bajwa, 2016, The Lancet.

Design of IPF Clinical Trials in the Era of Approved Therapies.

F. Martinez, J. Stauffer, L. Richeldi, 2019, American journal of respiratory and critical care medicine.

Death in hospital following ICU discharge: insights from the LUNG SAFE study

Karen E. Williams, Russell R. Miller, Samuel M. Brown, 2020, Critical Care.

Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

Arthur S Slutsky, J. Laffey, G. Rubenfeld, 2016, Intensive Care Medicine.

Cost and Utility of Microbiological Cultures Early After Intensive Care Unit Admission for Intracerebral Hemorrhage

Susan R. Wilcox, C. Camargo, D. Hess, 2017, Neurocritical Care.

Use of Phenobarbital in Alcohol Withdrawal Management - A Retrospective Comparison Study of Phenobarbital and Benzodiazepines for Acute Alcohol Withdrawal Management in General Medical Patients.

T. Wilens, G. Velmahos, E. Bajwa, 2019, Psychosomatics.

Measurement of high-sensitivity troponin T in noncardiac medical intensive care unit patients. Correlation to mortality and length of stay.

K. Lewandrowski, B. Thompson, J. Januzzi, 2014, American journal of clinical pathology.

Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk.

Xihong Lin, F. Chen, D. Christiani, 2015, Chest.

Vitamin D Status and Clinical Outcomes in Acute Respiratory Distress Syndrome: A Secondary Analysis From the Assessment of Low Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury (ALVEOLI) Trial

C. Camargo, B. Thompson, I. Bhan, 2021, Journal of intensive care medicine.

Acute Respiratory Distress Syndrome After Spontaneous Intracerebral Hemorrhage*

Susan R. Wilcox, C. Camargo, D. Hess, 2013, Critical care medicine.

Sepsis and those who are "weak of heart".

J. Januzzi, E. Bajwa, R. V. van Kimmenade, 2008, Critical care medicine.

ST2 Predicts Mortality and Length of Stay in a Critically Ill Noncardiac Intensive Care Unit Population.

K. Lewandrowski, J. Januzzi, E. Bajwa, 2016, American journal of clinical pathology.

Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor–Binding Protein-3 in Critical Illness*

C. Mantzoros, D. Christiani, L. Su, 2015, Critical care medicine.

Whole blood microRNAs as a prognostic classifier for acute respiratory distress syndrome 28-day mortality

L. Liang, A. Baccarelli, D. Christiani, 2016, Intensive Care Medicine.

Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.

E. Bajwa, S. Di Somma, Q. Truong, 2016, The American journal of medicine.

Case records of the Massachusetts General Hospital. Case 39-2012. A 55-year-old man with alcoholism, recurrent seizures, and agitation.

P. Schaefer, E. Bajwa, F. Smith, 2012, The New England journal of medicine.

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study

Karen E. Williams, Russell R. Miller, Samuel M. Brown, 2020, Critical Care.

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study.

Arthur S Slutsky, J. Laffey, G. Rubenfeld, 2017, The Lancet. Respiratory medicine.

24-hour on-site intensivist in the intensive care unit: yes.

E. Bajwa, R. Cartin-Ceba, 2010, American journal of respiratory and critical care medicine.

Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis.

A. Malhotra, N. Ayas, J. Ryu, 2005, Chest.

Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure : Plasma sST2 and Ventilator Liberation in AHRF

Sowmya R. Rao, Josalyn L Cho, B. Medoff, 2021 .

Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.

F. Chen, D. Christiani, M. Gong, 2010, Chest.

The influence of infection sites on development and mortality of ARDS

F. Chen, D. Christiani, M. Gong, 2010, Intensive Care Medicine.

ST2 in Pulmonary Disease.

A. Mebazaa, J. Januzzi, E. Bajwa, 2015, The American journal of cardiology.

Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data

E. Bajwa, S. Rajpathak, D. Lautsch, 2022, BMC Pulmonary Medicine.

Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Ognjen Gajic, Daniel Talmor, Murat Yilmaz, 2011, American journal of respiratory and critical care medicine.

Acute Lung Injury: Time to Find a Way That Works

E. Bajwa, 2011, Respiratory Care.

Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial

C. Camargo, I. Bhan, M. Kaneki, 2015, Critical care medicine.

Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients

R. Walensky, R. Parker, E. Bajwa, 2016, Open forum infectious diseases.

Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

Arthur S Slutsky, J. Laffey, G. Rubenfeld, 2017, Intensive Care Medicine.

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.

M. Exline, J. Christman, K. Delucchi, 2019, The Lancet. Respiratory medicine.

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

B. Thompson, A. Leavitt, M. Matthay, 2015, The Lancet. Respiratory medicine.

Methods of Monitoring Shock

A. Malhotra, B. Thompson, E. Bajwa, 2004, Seminars in respiratory and critical care medicine.

Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin

G. O’Keefe, D. Christiani, M. Wurfel, 2012, Journal of Medical Genetics.

Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome

D. Christiani, B. Thompson, M. Matthay, 2013, Critical care medicine.

Prognostic Significance of Elevated Cardiac Troponin-T Levels in Acute Respiratory Distress Syndrome Patients

D. Christiani, M. Gong, B. Thompson, 2012, PloS one.

Plasma C-reactive protein levels are associated with improved outcome in ARDS.

D. Christiani, M. Gong, B. Thompson, 2009, Chest.

Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome*

B. Thompson, M. Matthay, J. Januzzi, 2016, Critical care medicine.

Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome*

D. Christiani, M. Gong, B. Thompson, 2008, Critical care medicine.

Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome*

D. Christiani, M. Gong, B. Thompson, 2007, Critical care medicine.

Whole blood microRNA markers are associated with acute respiratory distress syndrome

L. Liang, A. Baccarelli, D. Christiani, 2017, Intensive Care Medicine Experimental.

Plasma Soluble Suppression of Tumerogenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure.

Sowmya R. Rao, Josalyn L Cho, B. Medoff, 2021, American journal of respiratory and critical care medicine.

Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome*

D. Christiani, M. Gong, B. Thompson, 2007, Critical care medicine.

Role of Diabetes in the Development of Acute Respiratory Distress Syndrome*

D. Christiani, M. Gong, B. Thompson, 2013, Critical care medicine.

Previous Studies Which Examined the Relationship between Diabetes and Development of Acute Respiratory Distress Syndrome

D. Christiani, M. Gong, B. Thompson, 2013 .

Elevated Red Cell Distribution Width Is Associated With Decreased Ventilator-Free Days in Critically Ill Patients

D. Yeh, R. Azocar, Andrea Tsai, 2018, Journal of intensive care medicine.

The genetics of acute lung injury: looking back and pointing the way forward

E. Bajwa, 2009, Critical care.

Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation

David T. Huang, Christopher M. Keener, W. Self, 2022, Intensive Care Medicine Experimental.

Objective : To characterize predictors of insulin-like growth fac- tor-1 and insulin-like growth factor–binding protein-3 in acute critical illness with the hypothesis that acute factors associated with critical illness will more strongly predict circulating insulin-like growth factor-1 and insulin-

C. Mantzoros, D. Christiani, L. Su, 2015 .

Plasma Gelsolin Depletion and Circulating Actin in Sepsis—A Pilot Study

T. Stossel, D. Christiani, P. Lee, 2008, PloS one.

The Presence of Diffuse Alveolar Damage on Open Lung Biopsy Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.

B. Thompson, L. Papazian, E. Bajwa, 2016, Chest.

BCL2 genetic variants are associated with acute kidney injury in septic shock*

F. Chen, D. Christiani, M. Gong, 2012, Critical Care Medicine.

Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

Arthur S Slutsky, J. Laffey, J. Chiche, 2019, Anesthesiology.

Biomarkers of sleep apnea.

A. Malhotra, E. Bajwa, S. Montesi, 2012, Chest.

Perspectives of continuous renal replacement therapy in the intensive care unit: a paired survey study of patient, physician, and nurse views

I. Bhan, E. Bajwa, A. Allegretti, 2015, BMC Nephrology.

Predicting Risk of Postoperative Lung Injury in High-risk Surgical Patients: A Multicenter Cohort Study

D. Talmor, J. Blum, M. Gong, 2014, Anesthesiology.

Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study

F. Chen, D. Christiani, L. Su, 2017, Intensive Care Medicine.

Sepsis-Associated Acute Kidney Disease

David T. Huang, Christopher M. Keener, Henry E. Wang, 2020, Kidney international reports.

Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome

E. Bajwa, Sean D Levy, 2018 .

A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline

Xihong Lin, D. Christiani, Feng Chen, 2017, American journal of respiratory and critical care medicine.

Effects of a New Hospital-Wide Surgical Consultation Protocol in Patients with Clostridium difficile Colitis.

D. King, G. Velmahos, M. D. de Moya, 2017, Surgical infections.

An NFKB1 Promoter Insertion/Deletion Polymorphism Influences Risk and Outcome in Acute Respiratory Distress Syndrome among Caucasians

D. Christiani, M. Gong, R. Zhai, 2011, PloS one.

Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study

I. Bhan, E. Bajwa, D. Steele, 2013, Critical Care.

Statin therapy as prevention against development of acute respiratory distress syndrome: An observational study*

D. Christiani, M. Gong, B. Thompson, 2012, Critical care medicine.

Deterioration of Regional Lung Strain and Inflammation during Early Lung Injury

K. Grogg, K. Hibbert, E. Bajwa, 2018, American journal of respiratory and critical care medicine.

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

R. Hyzy, D. Talmor, C. Cairns, 2017, The Lancet Respiratory Medicine.

Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome.

E. Benjamin, K. Hibbert, E. Bajwa, 2015, Journal of critical care.

Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients

C. Camargo, E. Bajwa, S. Quraishi, 2016, Journal of Intensive Care.

A Randomized Study of Immune Plasma for the Treatment of Severe Influenza

M. Hughes, C. Cairns, J. Metcalf, 2017 .

Clustering analysis to identify distinct spectral components of encephalogram burst suppression in critically ill patients

Patrick L. Purdon, M. Brandon Westover, Oluwaseun Akeju, 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

A Large-Scale Genetic Association Study Identifies Different Susceptibility Loci Of Sepsis-Related And Non-Sepsis-Related ARDS

H. Hakonarson, Xihong Lin, D. Christiani, 2010, ATS 2010.

Advanced imaging use in intensive care units has decreased, resulting in lower charges without negative effects on patient outcomes.

M. Eikermann, E. Bajwa, Jarone Lee, 2015, Journal of critical care.

Effects of an inhaled soluble guanylate cyclase (sGC) stimulator MK-5475 in pulmonary arterial hypertension (PAH).

E. Bajwa, J. Palcza, J. Denef, 2022, Respiratory Medicine.

Body mass index is associated with the development of acute respiratory distress syndrome

E. Bajwa, David C. Christiani, M. N. Gong, 2009, Thorax.

Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study.

Arthur S Slutsky, J. Laffey, J. Chiche, 2019, Anesthesiology.

Patient-Specific Classification of ICU Sedation Levels From Heart Rate Variability*

Patrick L. Purdon, M. Brandon Westover, Oluwaseun Akeju, 2017, Critical care medicine.

Targeting of functional antibody-CD59 fusion proteins to a cell surface.

S. Morrison, J. Yu, E. Bajwa, 1999, The Journal of clinical investigation.

Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

G. Rubenfeld, A. Slutsky, K. Kurahashi, 2016, Intensive Care Medicine.